Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Tempus said it will collaborate with Moderna and Merck over a multiyear effort to support potential commercialization of intismeran autogene, including handling tumor tissue and blood samples for next-generation sequencing.
Tempus said it has launched a multiyear collaboration with Moderna and Merck to support potential commercialization of a cancer drug candidate, intismeran autogene.